Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
Erowid References Database
Schifano F, Orsolini L, Duccio Papanti G, Corkery JM. 
“Novel psychoactive substances of interest for psychiatry”. 
World Psychiatry. 2015 Feb 06;14(1):15-26.
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, GABA-A/B receptor agonists, a range of prescribed medications, psychoactive plants/herbs, and a large series of performance and image enhancing drugs. Users are typically attracted by these substances due to their intense psychoactive effects and likely lack of detection in routine drug screenings. This paper aims at providing psychiatrists with updated knowledge of the clinical pharmacology and psychopathological consequences of the use of these substances. Indeed, these drugs act on a range of neurotransmitter pathways/receptors whose imbalance has been associated with psychopathological conditions, including dopamine, cannabinoid CB1, GABA-A/B, 5-HT2A, glutamate, and k opioid receptors. An overall approach in terms of clinical management is briefly discussed.
Notes # : erowid cited twice
Comments and Responses to this Article
Status: display
Oct 11, 2016 21:59
Erowid Badly Cited #

Erowid is cited a number of times in this paper, which we really appreciate. But all of the citations are to a generic (, despite referencing very specific pieces of information. Some appear to be references to experience reports, some to our summary pages. Thanks for using erowid, thanks for mentioning that you used erowid in your paper, but citing erowid twelve times for twelve different facts is like citing The New York Public Library as a source for a specific medical interaction.

Twelve citations to and three to erowid's online version of the Shulgins's TiHKAL.

Submit Comment
[ Cite HTML ]